Yingbei Chen

29PUBLICATIONS
121CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Dec 11, 2025
Clinical and Molecular Characterization of KRAS-Mutated Renal Cell Carcinoma.

Andrea Lopez Sanmiguel, Yash S Khandwala, Kuo Fengshen

|Feb 25, 2025
Immune Checkpoint Blockade Response in Mucinous Tubular and Spindle Cell Carcinoma.

Simran Makker, Neil J Shah, Maria I Carlo

|Jun 26, 2023
Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancer.

Luigi Perelli, Federica Carbone, Li Zhang

|Nov 03, 2022
FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.

Joshua I Warrick, Wenhuo Hu, Hironobu Yamashita

|Oct 27, 2022
Renal Medullary Carcinomas Harbor a Distinct Methylation Phenotype and Display Aberrant Methylation of Genes Related to Early Nephrogenesis.

Victoria E Fincke, Mateja E Krulik, Piyush Joshi

|Jun 27, 2022
A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma.

Phillip M Rappold, Lynda Vuong, Josef Leibold

Pageof 5

Frequent Collaborators

6 joint publications

Martin H Voss

6 joint publications

James J Hsieh

6 joint publications

Robert J Motzer

6 joint publications

Fengshen Kuo